(Q40390484)

20 September 2017

title

Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination (English)

1 reference

20 September 2017

1 reference

Steitz J

1

1 reference

20 September 2017

Tormo D

series ordinal

2

1 reference

20 September 2017

Schweichel D

series ordinal

3

1 reference

20 September 2017

Tüting T

series ordinal

4

1 reference

20 September 2017

publication date

1 March 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

318-325

1 reference

Tumor antigens recognized by T cells

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Dendritic cells as vectors for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Current developments in cancer vaccines and cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

7 January 2021

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

7 January 2021

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

7 January 2021

CD8 and B cell memory: same strategy, same signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700894

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700894

1 reference

Dimensions Publication ID

20 September 2017

1006913690

0 references

1 reference